TUC3PII-01_TU2670 Phase IIa Clinical Study
NCT05138562
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
86
Enrollment
INDUSTRY
Sponsor class
Conditions
Endometriosis
Interventions
DRUG:
Placebo Comparator: Placebo
DRUG:
Active Comparator: TU2670 320mg
DRUG:
Active Comparator: TU2670 240mg
DRUG:
Active Comparator: TU2670 120mg
Sponsor
TiumBio Co., Ltd.